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Abstract
Background: The anatomical variants of the relations of the left circumflex artery (LCx) and 
the coronary sinus (CS) determine the safety of percutaneous mitral annuloplasty (PMA) as 
an occlusion of the LCx and its consequences might occur in some cases. Thus, knowledge of 
the anatomy of cardiac anatomy and any variations are important for surgeons. 
Methods: In 320 (126 women, age 59 ± 11) patients, a  64-slice computed tomography 
(MSCT) (Aquilion 64) was performed due to a suspicion of coronary artery disease. A scan 
with ECG-gating was performed using a  slice thickness of 0.5 mm during a  breath-hold. 
The helical pitch was 12.8, rotation time: 0.4 s and average tube voltage: 135 kV at 380 mA. 
100 mL of non-ionic contrast agent was given in three phases at an average rate of 4.5 mL/s. 
In each case, ten 3D volume rendering and 2D multiplanar reconstructions of the vessels were 
created (Vitrea 2). 
Results: The CS was visualized in all cases and the LCx in 315 (98.4%). In 302 (95.8%) 
cases, the CS was the dominant vessel; in 10 (3.17%) cases both vessels were equal and the LCx 
was dominant in only 3 (0.9%) cases. 52 anatomical variants were identified; 3 of them were 
the most common (in 164/315 cases; 50.8%). The CS usually lies above the atrioventricular 
(AV) sulcus (239–75.9%) and the LCx within the AV sulcus (173–54.9%). In 235 (74.6%) 
cases, the LCx was closer (than the CS) to the mitral valve. It was found that in 78 (24.7%) 
cases, the LCx was beneath the CS in selected phases (a risk of LCx occlusion by a PMA de-
vice). The LCx closer to the mitral valve, which is considered as a safe feature for PMA, was 
observed in only 75 (23.8%) of the cases. The most dangerous pattern was found in 19 cases 
(6.1%) — 2 or 3 CS/LCx crosses.
Conclusions: The huge anatomical variability of the anatomy of the CS/LCx strengthens the 
role of MSCT before PMA implantation. (Cardiol J 2013; 20, 3: 235–240)
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Introduction
Percutaneous mitral annuloplasty (PMA) can 
be an alternative method of treatment for patients 
with ischemic mitral regurgitation [1, 2]. In this 
method, the circumference of the mitral annulus 
is reduced in the antero-posterior diameter by 
a dedicated device such as e.g. a CARILLON (Car-
diac Dimensions, USA). Devices are implanted 
percutaneously via the coronary sinus (CS) ostium 
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from the right atrium and finally into the CS and 
great cardiac vein. It usually consists of two parts 
— the proximal part in the CS ostium and the distal 
part in the distal great cardiac vein [1, 3]. The two 
parts are connected by a “bridge” that reduces the 
circumference of the mitral annulus. The results 
of a CARILLON Mitral Annuloplasty Device Euro-
pean Union Study (AMADEUS) proved that using 
the CARILLON is feasible in patients with heart 
failure (HF) and is associated with a low incidence 
of major adverse events and is associated with an 
improvement in quality of life and exercise toleran-
ce [4]. The latest study — TITAN (Trans catheter 
Implantation of Carillon Mitral Annuloplasty De-
vice) proved that percutaneous CS-based mitral 
annuloplasty can significantly and safely reduce 
functional mitral regurgitation in HF patients. It 
was also documented that left ventricle reverse 
remodeling occurred over 12 months and that 
improved measures of clinical outcome occurred 
over 24 months [5]. 
The anatomical variants of relations of the left 
circumflex artery (LCx) and the CS determine the 
safety of PMA as an occlusion of the LCx and its 
consequences might occur in some cases. Thus, 
knowledge of the anatomy of the cardiac vessels 
and any variations are important for surgeons. 
Multi-slice computed tomography (MSCT) allows 
the visualization of the relationships between the 
mitral valve (MV), the LCx and the CS so that the 
risk of occluding the LCx can be minimized [3, 6]. 
In our previous study, we documented how to 
visualize the LCx and CS in MSCT [6]. However, 
there is still the question of which anatomical va-
riants CS/LCx/MV can be met by PMA operators. 
In this study, we used our previous experience to 
describe the anatomy of the relations of the struc-
tures of the heart that are necessary for PMA and 
found anatomical variants of the CS/LCx with the 
mitral valve.
Methods 
The data for 320 consecutive patients (126 wo-
men, aged 59 ± 11) from 64-slice computed to-
mography (Aquilion 64, Toshiba Medical, Japan) 
was retrospectively analyzed in order to evaluate 
the CS, LCx and MV annulus. MSCTs of the heart 
were originally performed due to a suspicion of 
coronary artery disease (CAD). Patients were 
excluded if the image quality was not diagnostic 
for the research purpose. 
The local Ethics Committee approved the 
study protocol. The study protocol conformed to 
the version of the Helsinki Convention that was 
current at the time the study was designed.
Computed tomography procedure
Scanning with retrospective ECG-gating was 
performed during a breath-hold using 64 slices with 
a collimated slice thickness of 0.5 mm. A breath-hold 
examination was performed in order to adjust the 
scanner settings. The helical pitch was 12.8 (best 
mode) and the rotation time was 0.4 s. The tube 
voltage was strictly dependent on the patient’s body 
mass index (BMI): for BMI < 23.9 it was 120 kV at 
330 mA, for BMI = 24.0–29.9 it was 135 kV at 380 mA 
and for BMI > 30.0 it was 135 kV at 430 mA. We 
used a pre-selected region of interest (ROI) in the 
descending aorta. Triggering started at 180 Houns-
field units. On average, 100 mL of non-ionic contrast 
agent (Ioperamid, Ultravist 370, Schering, Germany) 
was given to each patient during the examination at 
an average rate of 4.5 mL/s. The contrast agent was 
given in three phases: 90 mL of contrast agent (avera-
ge), then 24 mL of contrast agent followed by 16 mL 
of saline flush (60%/40%) and finally 30 mL of saline. 
The cut-off for heart rate (HR) was set at 65 bpm. If 
the HR was higher, metoprolol succinate (Betaloc, 
Astra Zeneca, Sweden) at a dosage of 5–10 mg was 
given intravenously, unless contraindicated. If the 
expected HR slowing did not occur, the patient was 
excluded from the study. Sublingual nitroglycerin was 
not given before image acquisition.
Computed tomography reconstruction
Reconstructions of the data were performed 
retrospectively on Vitrea 2 workstations (Vital 
Images, USA; software version 3.9.0.0 and 5.1). In 
each case, we created ten axial image series as well 
as 3D volume rendering (VR) reconstructions from 
0% to 90% R-R intervals (step 10%) using a 2.0 mm 
slice thickness in order to reduce the large amount of 
data. Earlier publications including studies from our 
unit have sho wn that the phase of the RR interval at 
which reconstructions are performed is an important 
factor that affects the quality of the visualization 
[6–9]. This is especially important when vessels 
other than coronary arteries need to be analyzed. 
Based on the results from our previous paper, thanks 
to retrospective gating, reconstructions of the pa-
rallel visualization of both the LCx and the CS to 
determine the relations between these vessels was 
performed in the 70–80% RR phase. An additional 
independent reconstruction that is optimal for the 
LCx (70–80% RR) as well as the CS (30–40–50% 
RR) was also performed. The dominant vessel was 
judged to be the larger vessel.
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Results
The hemodynamic characteristics of the pa-
tients are presented in Table 1. 
Anatomy of the heart in cardiac computed to-
mography is presented in the Figure 1. The CS was 
visualized in all cases and the circumflex branch of 
the left coronary artery in 315 (98.4%) cases. In 
302 (95.8%) cases, the CS was the dominant vessel, 
in 10 (3.2%) both vessels were equal and the LCx 
was dominant in only 3 (0.9%) cases. 
The CS was usually above the atrio-ventricular 
(AV) sulcus in the atrial direction (239 cases; 
75.9%), in 72 (22.8%) cases it was under and in 
4 (1.3%) cases it was in the sulcus. The LCx was 
usually within the AV sulcus (173 cases; 54.9%), 
in 67 cases below it (21.3%) and in 66 cases above 
(20.9%) it. In 9 (2.9%) cases, it was not possible to 
evaluate the LCx. In tomographic images, the AV 
sulcus should be identified with the MV annulus. 
In 235 (74.6%) cases, the LCx was closer (than the 
CS) to the mitral  (Fig. 2A).
Table 1. Average  values (min, max, SD) of the main cardiac function parameters for the patients included.
Average value Min. value Max. value SD
Ejection fraction [%] 62.0 8 86 ± 10.48
End-diastolic volume [mL] 145.42 69 464 ± 44.69
End-systolic volume [mL] 58.43 11 425 ± 37.82
Stroke volume [mL] 87.18 39 151 ± 20.11
Cardiac output [L/min] 5.38 1,8 13,9 ± 1.54
Myocardial mass [g] 140.91 60 371 ± 45.37
Myocardial volume [mL] 131.91 13 352 ± 43.57
Heart rate [bpm] 61.54 20 157 ± 10.36
Figure 1. Anatomy of the heart in cardiac computed to-
mography — 3DVR; LA — left atrium; LV — left ventricle.
Figure 2. Examples of anatomical variants coronary sinus (CS)/left circumflex (CX) in cardiac computed tomography — 3DVR.
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Figure 3. The most common variant of coronary sinus (CS)/left circumflex (LCx) artery in cardiac computed tomo-
graphy — 3DVR.
Table 2. The most common anatomical variants found in this study.
No. Dominant 
vessel
Localization 
CS                    LCx
Vessel 
higher
Number  
of crosses
Vessels close  
to the sulcus
Frequency 
cases/%
1 CS Above  
sulcus
In sulcus CS 1 LCx 107/33.9
2 CS Above  
sulcus
Beneath  
sulcus
CS 1 LCx 30/9.5
3 CS Above  
sulcus
Above  
sulcus
CS 1 LCx 27/8.6
4 CS In sulcus In sulcus CS 1 LCx 15/4.8
5 CS Above  
sulcus
In sulcus CS 1 CS 11/3.5
6 CS Above  
sulcus
Beneath  
sulcus
CS 1 CS 10/3.2
CS — coronary sinus; LCx — circumflex artery
In 78 (24.7%) cases, the LCx entered beneath 
the CS in selected phases (not all). In those patients 
there was risk of LCx occlusion by a PMA device. 
The LCx running closer to the MV, which is con-
sidered as a safe feature for PMA, was observed in 
only 75 (23,8%) cases (Fig. 2B). The most dangerous 
pattern where 2 or 3 CS/LCx crosses occurred was 
found in 19 (6.1%) cases (Fig. 2C).
It was possible to identify 52 anatomical va-
riants in the examined population. Three of them 
are the most common (they were identified in 164 
of the 315 cases; 50.8%). The 6 most frequent 
variants are presented in Table 2. In the most 
frequent anatomical variant, the CS lies above the 
AV sulcus and the LCx in the AV sulcus and can 
potentially cause problems during the implantation 
of PMA devices. In this variant, there is one cross 
CS/LCx and vessel close to the sulcus is LCx. This 
variant is presented in Figure 3. 
Discussion 
The safety and usefulness of PMA has been 
confirmed in human studies such as e.g. AMA-
DEUS and lately the TITAN trials [4, 5, 10]. In 
48 patients enrolled in the AMADEUS trial the 
major adverse event rate was 13% at 30 days [4]. 
At 6 months, the degree of mitral regurgitation 
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reduction ranged from 22% to 32%. Six-minute 
walk distance improved from 307 ± 87 m to 403 ± 
± 137 m at 6 months (p < 0.001). Quality of life 
also statistically improved (p < 0.001). 
In the latest PMA study — TITAN study — 
the 30-day major adverse event rate was 1.9% [5]. 
Reductions of mitral regurgitation represented 
by regurgitant volume was observed (34.5 ± 
± 11.5 mL to 17.4 ± 12.4 mL at 12 months; 
p < 0.001). Authors concluded that percutaneo-
us reduction of mitral regurgitation using a CS 
approach is associated with reverse left ventri-
cular remodeling. 
One of the important factors that determine 
the success of a procedure is to avoid LCx com-
pression by a PMA device. This strictly depends on 
the anatomical relationships between the LCx and 
the CS. MSCT can precisely document the anatomy 
of the coronary arteries and coronary veins [3, 6]; 
however, this knowledge should be confirmed by 
anatomo-pathological studies. 
In 2006 Maselli et al. [11] published the results 
of an anatomical study of the human CS in relation 
to the MV and coronary arteries in 61 excised 
cadaveric human hearts. They found that the LCx 
lies between the CS and the MV annulus in 63.9% 
— in our study it was 74.6%.
In 2007 Tops et al. [12] analyzed 105 con-
secutive patients referred for MSCT corona-
ry angiography. The patients were divided into 
3 groups according to the presence of CAD and HF. 
They concluded that the LCx, CS and MV can be ana-
lyzed in MSCT. This paper is relevant to our study as 
they used the same MSCT scanner with retrospective 
gating. They found that in 68% of the patients, the LCx 
coursed between the CS and the mitral annulus — in 
our study it was 74.6%. At the level of the MV annulus, 
the CS was located more superiorly in 90% in their 
study — in our study 72.8%. 
In the next paper from 2008, Plass et al. [13] 
analyzed the relations of the LCx/CS in normal and 
insufficient MV. In this research, the CS was usually 
(in 34%) positioned at the same level as the MV 
and in 54% of the cases, it was above the annulus. 
Those results are similar to our results — 75.8% and 
21.3%, respectively. Swiss authors also found that in 
33% of patients, the LCx ran under the CS — in our 
research it was 24.7%. Cited paper is one of the first 
analyses of CS/LCx relations using MSCT; however, 
the examined group is rather small when compared 
to our study (50 to 320 patients).
Mao et al. [14] examined 231 patients using 
electron-beam computed tomographic angiography 
(EBCTA) — they concluded that EBCTA can pro-
vide a 3-D visualization of most of the components 
of the coronary venous system in relation to the 
coronary arteries. They also found that in 80.8% of 
the cases, the LCx lies deeper than the CS, which 
is consistent with our results. 
The authors cited above did not try to find any 
anatomical variants and only relations were exa-
mined and the results of those relations are com-
parable to ours. To the best of our knowledge, our 
paper is the first, large-scale study (320 patients 
included) where anatomical variants, the CS/LCx/ 
/MV, are presented.   
Fortunately, recently published results about 
the implantation of PMA devices have proved 
that the number of problems is smaller than the 
anatomy of the key vessels from the cited resear-
ches have shown. In the TITAN study, only two 
myocardial infarctions were found during follow-up 
in the implanted cohort and analysis showed that 
neither were PMA device related [5].
In our opinion, problems can also be caused 
by dynamic changes (the LCx moving in relation 
to the CS). This thesis is only based on observa-
tion, to date, it has not been scientifically proved; 
however, it seems that in different phases of the 
cardiac cycle, the anatomical relations between 
both vessels can change significantly. 
Further clinical research in PMA implantation 
will evaluate any potential problems and clinical 
pitfalls. Data from this paper should be made avail-
able to people performing PMA implantations. 
There are no simple transpositions of anatomical 
findings (either anatomical or tomographic) into 
problems or accidental LCx occlusion that might 
occur during PMA implantation.  
It is necessary to mention that there are also 
another methods which can reduce mitral regurgi-
tation and are not anatomy CS/MV dependent. An 
example of such system is the MitraClip (Abbott, 
USA) which is a catheter-based less-invasive the-
rapy for MV repair. To access the MV, the guide 
catheter is inserted into the femoral vein to reach 
the heart and deploys the MitraClip device. In latest 
research overall MitraClip procedural success rate 
was 96.5% with an in-hospital mortality rate of 3.5% 
[15]. Next few years will show which methods will 
get more outcomes for mitral regurgitation patients. 
Limitations of the study
This study is a descriptive anatomical study. 
At the time of its publication, the Authors have no 
practical experience with PMA. We believe that 
the experience of surgeons is a critical factor in 
the success of the procedure.
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Conclusions
It is possible to visualize the CS, the circum-
flex branch of the left coronary artery and the MV 
annulus using cardiac computed tomography. The 
huge anatomical variability of the anatomy of the 
CS and the circumflex branch of the left coronary 
artery strengthens the potential role of performing 
computed tomography before PMA. In the most 
frequent anatomical variant, the CS lies above the 
AV sulcus and the LCx in the AV sulcus and can 
potentially cause problems during the implantation 
of PMA devices.
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